Tag Archives: Tufts Center for the Study of Drug Development

Paring the Fat in Clinical Trials

By William Looney | Published: July 18, 2012
Is too much irrelevant data slogging the pace to registration? Conclusions of a Pharm Exec May 15 Roundtable on finding ways to build efficiencies into an increasingly costly and complex clinical trials process have been bolstered by new research from the Tufts Center for the Study of Drug Development. Based on extensive survey data drawn [...]
Posted in Op-Ed, R&D | Also tagged | 3 Comments

Talkback from Tufts: Defending R&D Costs

By Guest Blogger | Published: February 13, 2012
by Joe DiMasi, director of economic analysis, Tufts Center for the Study of Drug Development William Looney’s posting for this blog, “Calculating the Cost of R&D: Defending Tufts Research” (January 11, 2012), raises a number of interesting and important points.  Both the posting and the working paper by F.M. Scherer on which the posting was based, [...]
Posted in Guest Blog, R&D, pricing | Also tagged , | 2 Comments

Calculating the Cost of R&D: Defending Tufts Research

By William Looney | Published: January 11, 2012
Estimates of what it takes to deliver a compound to market are more than an academic exercise — such data has an increasingly important on-the-ground impact on industry revenues,  because if you cannot justify your costs how do you expect to prevail on price?   
Posted in Op-Ed, R&D, pricing | Also tagged , , , , | 1 Comment